trial

Mindfulness-based Illness Management Program for Schizophrenia

NCTId NCT01667601
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 449 (actual)
Sponsored by The Hong Kong Polytechnic University
Primary completion 2016-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
449 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2010-08
Primary completion
2016-06
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
Routine CareMindfulness-based programpsychoeducation group

Sponsors

The Hong Kong Polytechnic UniversityLead Sponsor
Hospital Authority, Hong KongCollaborator
Jilin Medical College, ChinaCollaborator
Taipei Medical University Shuang Ho HospitalCollaborator

Investigators

1
Chien WT, PhDPrincipal Investigator

Sites

4 total
Jilin City, ChinaShatin, Hong KongTuenmen, Hong KongTaipei, Taiwan

Facts & assertions

4 sourced
Enrollment
449
Phase
NA
Primary Completion Date
2016-06
Status
COMPLETED
relationships
The graph out of here
drug
Routine Care
drug
Mindfulness-based program
drug
psychoeducation group
drug
lead_sponsor
The Hong Kong Polytechnic University
company
collaborator
Hospital Authority, Hong Kong
company
Jilin Medical College, China
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Chien WT, PhD
person